Friday, October 9, 2015: 10:30 AM-12:00 PM
Room: 6--DE
Learning Objectives:
At the conclusion of this session, participants will be able to:
- describe new treatment options for hepatitis C and their use with patients
- summarize the latest treatment recommendations for patients with hepatitis C
- discuss how to diagnose and manage advanced liver disease
Target Audience: Public health practitioners, Infectious diseases physicians, Members-in-training, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Clinicians, Academicians
Tracks: Trainee, HIV-STD-TB, Adult ID
Moderators:
Pablo Tebas, MD, FIDSA, University of Pennsylvania
and
Michael T. Melia, MD, Johns Hopkins University School of Medicine
Presentations:
CME Credits: Maximum of 1.5 hours of
AMA PRA Category 1 CreditTM
ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE
ACPE Number: 0221-9999-15-174-L01-P
Disclosures:
P. Tebas,
Merck:
Consultant
,
Consulting fee
Glaxo:
Consultant
,
Consulting fee
M. T. Melia,
industry:
Grant Investigator
,
Research support